Atorvastatin magnesium

This classification denotes a hmg-coa reductase inhibitor 2C33H34FN2O5.Mg, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IVW98J023E, chemically known as magnesium, bis((.beta.r,.delta.r)-2-(4-fluorophenyl)-.beta.-(hydroxy-.kappa.o)-.delta.-hydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoato-.kappa.o1)-, (t-4)-, but more generally known as atorvastatin magnesium, which bears US NIH Compound Identifier 11651062. European Medicines Agency schedules Atorvastatin magnesium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB51445. Most nations, for tariff and trade purposes, schedule atorvastatin magnesium under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN MAGNESIUM remains US FDA's Preferred Term for this commodity. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.[MG+2].